Peter Jenkins - CardieX Independent Non-Executive Director
Director
Mr. Peter R. Jenkins DSc has resigned as Independent NonExecutive Director of AtCor Medical Holdings Limited. effective 13 November 2015. He has served on the AtCor Groups Board since 2000 including 4 years as chairman. He is a Consultant to Colonial First State Private Equity until his retirement in December 2005. Previously he had over 30 years experience in the pharmaceutical and medical diagnostics industry.
Age | 78 |
Phone | 61 2 9874 8761 |
Web | http://cardiex.com |
CardieX Management Efficiency
The company has return on total asset (ROA) of (16.43) % which means that it has lost $16.43 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (48.97) %, meaning that it generated substantial loss on money invested by shareholders. CardieX's management efficiency ratios could be used to measure how well CardieX manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 1.7 M in total debt with debt to equity ratio (D/E) of 0.24, which may suggest the company is not taking enough advantage from borrowing. CardieX Limited has a current ratio of 1.67, which is within standard range for the sector. Debt can assist CardieX until it has trouble settling it off, either with new capital or with free cash flow. So, CardieX's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardieX Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardieX to invest in growth at high rates of return. When we think about CardieX's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Franklin Miller | Merit Medical Systems | 76 | |
Patrick Hanley | Old Dominion Freight | 73 | |
David Liu | Merit Medical Systems | 43 | |
Michael Wray | Old Dominion Freight | 57 | |
Elliott Bisnow | Lindblad Expeditions Holdings | 32 | |
Katharine Reynolds | Lindblad Expeditions Holdings | N/A | |
Brian Stern | HNI Corp | 71 | |
Dirk Junge | LB Foster | 69 | |
Scott Anderson | Merit Medical Systems | 70 | |
Lawrence Calcano | Lindblad Expeditions Holdings | 53 | |
Robert Purgason | LB Foster | 62 | |
Dyson Dryden | Lindblad Expeditions Holdings | 42 | |
James Jenkins | HNI Corp | 69 | |
Richard Donaldson | Lindblad Expeditions Holdings | 56 | |
Larry Porcellato | HNI Corp | 62 | |
Jill Anderson | Merit Medical Systems | 58 | |
Cheryl Francis | HNI Corp | 67 | |
Diane Owen | LB Foster | 62 | |
John Kasarda | Old Dominion Freight | 72 | |
John Fahey | Lindblad Expeditions Holdings | 66 | |
Nolan Karras | Merit Medical Systems | 72 |
Management Performance
Return On Equity | -48.97 | |||
Return On Asset | -16.43 |
CardieX Limited Leadership Team
Elected by the shareholders, the CardieX's board of directors comprises two types of representatives: CardieX inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CardieX. The board's role is to monitor CardieX's management team and ensure that shareholders' interests are well served. CardieX's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CardieX's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rhonda Welch, Vice President of Global Marketing | ||
David Brookes, Independent Non-Executive Director | ||
Mark Harding, VP of Global Marketing and International Sales - Atcor Medical Pty Ltd | ||
Niall Cairns, Non-Executive Director | ||
Chris Dax, Vice President - Operations | ||
Peter Jenkins, Independent Non-Executive Director | ||
Craig Cooper, CEO, Executive Director | ||
Duncan Ross, CEO, Managing Director, Executive Director | ||
Randall Nelson, Independent Non-Executive Director | ||
Douglas Kurschinski, Sr. VP of Atcor Medical Inc and General Manager of Atcor Medical Inc | ||
Michael ORourke, Non-Executive Director | ||
Donal ODwyer, Independent Non-Executive Chairman of the Board | ||
Peter Manley, CFO, Company Secretary |
CardieX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is CardieX a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -48.97 | |||
Return On Asset | -16.43 | |||
Profit Margin | (61.97) % | |||
Operating Margin | (48.59) % | |||
Current Valuation | 32.61 M | |||
Shares Outstanding | 532.82 M | |||
Shares Owned By Insiders | 46.84 % | |||
Price To Earning | (1.47) X | |||
Price To Book | 5.00 X | |||
Price To Sales | 4.20 X |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as various price indices. Note that the CardieX Limited information on this page should be used as a complementary analysis to other CardieX's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in CardieX OTC Stock
If you are still planning to invest in CardieX Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CardieX's history and understand the potential risks before investing.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |